According to Jaideep Goswami, Head of Equity at ICICI Securities, pharma sector being export oriented sector will continue to outperform in at least first few months of the year.

Buy Torrent Pharmaceuticals on dips: SP Tulsian

SP Tulsian of sptulsian.com has a positive view on Torrent Pharmaceuticals and advises buying it on correction.

Buy Torrent Pharma, NIIT Tech, Radico Khaitan: Subramanium

Krish Subramanium of Asit C Mehta Invstt Intermediates recommends buying Rallis India for a target of Rs 173 and NIIT Technologies for a target of Rs 343.

Bull's Eye: Buy Apollo Tyres, Rallis India, Ashok Leyland

Nooresh Merani of Analyse India advises buying Chambal Fertiliser for a target price of Rs 43 and Godrej Industries for a target price of Rs 300.

Check Out: Super Six stocks for December 12

Shrikant Chouhan of Kotak Securities suggets buying Bata India with a target of Rs 1045-1060 and Zee Entertainment with a target of Rs 300.

Accumulate Infosys, Tech Mahindra: Nischal Maheshwari

Nischal Maheshwari of Edelweiss Financial Services is of the view that one may accumulate Infosys, Tech Mahindra and Persistent Systems from the IT space.

Buy Torrent Pharma, KPIT Tech; sell Voltas: Subramanium

According to Krish Subramanium of Asit C Mehta, one may buy Mangalore Refinery and Petrochemicals for a target of Rs 45.75 and advises selling Voltas for a target price of Rs 83.

Bull's Eye: Buy MRPL, KPIT Tech; sell PTC India, Voltas

Krish Subramanium of Asit C Mehta advises buying Mangalore Refinery and Petrochemicals for a target price of Rs 45.75 and Torrent Pharma for a target price of Rs 512.

Torrent Pharma has target of Rs 600: SP Tulsian

SP Tulsian of sptulsian.com is of the view that Torrent Pharmaceuticals has target of Rs 600. "The company has three plants in India. They have a very good presence worldwide. They have the unit in Brazil, US and in Germany," he adds.

Multibagger Picks: Torrent Pharma, Indraprastha Medical

SP Tulsian of sptulsian.com asks traders to keep a view of about six months and look for a target of Rs 500 on Torrent Pharmaceuticals. He expects Indraprastha Medical Corporation, which is now ruling at around Rs 33, to move to Rs 40 maybe in six months or so.

Bodke upbeat on Shree Cements, JK Bank, Bharat Electronics

Ajay Bodke of Prabhudas Lilladher Private Limited is upbeat on Shree Cements, Jammu and Kashmir Bank, Bharat Electronics.

Torrent Pharma can go above Rs 1000: SP Tulsian

Torrent Pharma can go above Rs 1000, says SP Tulsian, sptulsian.com. They had an EPS of close to about Rs 25 against Rs 34 EPS in whole of FY12 with PAT of close to about Rs 210 crore in the first half of FY13 against Rs 260-270 crore which they had in FY12.

Expect 24-25% upside in Torrent Pharma: Ajay Bodke

Expect 24-25% upside in Torrent Pharma, says Ajay Bodke of Prabhudas Lilladher. There the story is essentially of around 20 percent growth in earnings in the current and around 30 percent in the next financial year with a bottomline of around 25 percent CAGR in the current and next financial year.

Check out: Prabhudas Lilladher's largecap and midcap picks

Ajay Bodke of Prabhudas Lilladher says on ground implementation of reforms and the pace and extent of rate cuts, which the RBI could unveil post January, are the key events to watch, in addition to the contingence of the risk-on trade.

See good upside in Dr Reddy's, Divis, Torrent Pharma: IIFL

Bino Pathiparampil of IIFL is bullish on Dr. Reddy‘s, Divi‘s Laboratories and Torrent Pharma. These stocks have attractive valuations and strong growth prospects. "These three stocks have good upside even in this market," he told CNBC-TV18.

Enter Torrent Pharmaceuticals on dips: Anu Jain

Anu Jain, IIFL Private Wealth Management suggests to enter Torrent Pharmaceuticals on dips.

Buy Torrent Pharma for long term: Avinash Gorakshakar

Buy Torrent Pharma for long term, says Avinash Gorakshakar of Edelweiss Financial.

Torrent Pharma may touch Rs 680 levels: Bothra

Torrent Pharma may touch Rs 680 levels, says Kunal Bothra, LKP.

Bull's Eye: 12 must-have stocks for your portfolio

Bull's Eye, the popular game show on CNBC-TV18, offer investors a chance to have a look at the stocks that can be added to their portfolio.